Clinical trial Recruiting at 1 site Observational Ages 18 to 45

Predicting how coronary artery disease progresses in adults 45 and younger

Official title: Risk Prediction of Disease Progression in Early-Onset Coronary Atherosclerosis

Run by Fu Wai Hospital, Beijing, China · NCT07316452 · Data updated 2026-11-12

This project will try to build prediction models using coronary CT scans and health data from people aged 18–45 to see who is more likely to have plaque get worse over time.

More Coronary Disease trials

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexAll
Enrollment10000 (estimated)
SponsorFu Wai Hospital, Beijing, China
Academic / other
Locations1 site (Beijing)
StatusRecruiting
StartedJanuary 1, 2025
Main results expectedSeptember 1, 2027
Study endsJanuary 1, 2028
Registry record updatedJanuary 5, 2026
Trial IDNCT07316452 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–45 with symptoms suggestive of coronary artery disease who have completed a coronary CT, can provide informed consent, and are willing to attend follow-up visits are ideal candidates.

Probably not a fit

People with prior coronary revascularization, poor‑quality coronary CT images, severe life‑limiting systemic disease, pregnant or breastfeeding women, or those unable to complete follow‑up are unlikely to gain benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a large, multicenter observational effort across China enrolling about 10,000 participants aged 18–45 who undergo coronary CT. At enrollment the project collects basic health information, cardiovascular risk factors, blood test results, medication use, lifestyle habits, and optional genetic data for some participants. Participants will be asked to return for follow-up coronary CT scans after several years to measure changes in plaque and disease progression. The collected clinical and imaging data will be used to identify factors linked to progression and to build models that estimate future plaque progression and cardiovascular event risk.

Why it matters

Potential benefit: If successful, the models could help clinicians identify younger adults at higher risk so they can offer earlier prevention and monitoring to reduce future heart events.

How similar studies have gone: Previous observational cohorts have linked clinical risk factors and CT plaque features to progression, but large nationwide CT‑based prediction efforts specifically focused on young adults are relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age between 18 and 45 years at the time of enrollment.
2. Presence of symptoms suggestive of coronary artery disease and completion of coronary computed tomography (CT) examination.
3. Ability and willingness to provide written informed consent and to participate in follow-up assessments.

Exclusion Criteria:

1. Inability or unwillingness to complete follow-up assessments.
2. Inability to provide written informed consent.
3. History of coronary revascularization, including percutaneous coronary intervention or coronary artery bypass grafting.
4. Poor-quality coronary computed tomography images that are inadequate for reliable plaque assessment.
5. Presence of severe systemic disease with limited life expectancy that may interfere with study follow-up.
6. Pregnant or breastfeeding women.
7. Participation in another clinical study that may interfere with the outcomes of this study.

Where it's running

  • FuWai hospital
    Beijing, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.